Clinical Trial

Antibiotic Prophylaxis in Pediatric Open Fractures

Enrolling by Invitation Phase 4
View on ClinicalTrials.gov →
Summary
This research will involve a prospective study on infection rates after grade 1 or 2 open fractures in the skeletally immature pediatric population. There will be 3 arms: one dose intravenous cefazolin, 24 hours intravenous cefazolin, and 24 hours intravenous cefazolin plus 5 days of oral cephalexin.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2023-09-20; most recent amendment 2025-10-14.
Trial Details
NCT Number NCT06055712
Lead Sponsor St. Louis University
Conditions Fractures, Open, Infections
Enrollment 800 participants
Start Date 2023-09-11
Primary Completion 2033-09 (estimated)
Study Completion 2034-01 (estimated)
Updated on ClinicalTrials.gov 2025-10-20